FR4953M - - Google Patents
Info
- Publication number
- FR4953M FR4953M FR941651A FR941651A FR4953M FR 4953 M FR4953 M FR 4953M FR 941651 A FR941651 A FR 941651A FR 941651 A FR941651 A FR 941651A FR 4953 M FR4953 M FR 4953M
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US191392A US3254074A (en) | 1962-04-25 | 1962-04-25 | Spiroxenones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FR4953M true FR4953M (en:Method) | 1967-04-03 |
Family
ID=22705306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR941651A Expired FR4953M (en:Method) | 1962-04-25 | 1963-07-16 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3254074A (en:Method) |
| FR (1) | FR4953M (en:Method) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3424750A (en) * | 1966-04-28 | 1969-01-28 | Syntex Corp | 17-spirotetrahydrofuranyl and 17-oxospirotetrahydrofuranyl derivatives of the androstane series and the preparation thereof |
| US3509136A (en) * | 1968-07-30 | 1970-04-28 | Searle & Co | 3 - (17beta - hydroxy - 7alpha - (lower alkyl) thio-3-oxoandrost-4-en-17alpha-yl)propionic acid gamma-lactones and congeners |
| US3670079A (en) * | 1970-10-06 | 1972-06-13 | Merck & Co Inc | Anabolic agents |
| US3920806A (en) * | 1973-05-04 | 1975-11-18 | Merck & Co Inc | Growth promoting subcutaneous compositions |
| HU167833B (en:Method) * | 1973-07-09 | 1975-12-25 | ||
| US3939155A (en) * | 1974-06-28 | 1976-02-17 | G. D. Searle & Co. | 4',5'-Dihydrospiro[androst/estr-4-ene-17,2'(3'H)-furan]3,4'-dione and congeners, and intermediates thereto |
| US4054563A (en) * | 1975-04-25 | 1977-10-18 | Ciba-Geigy Corporation | Process for the manufacture of spiro compounds of the steroid series |
| DE2922500A1 (de) * | 1979-05-31 | 1980-12-04 | Schering Ag | 6 beta .7 beta |
| DK465481A (da) * | 1980-11-21 | 1982-05-22 | Hoffmann La Roche | Fremgangsmaade til fremstilling af d-homostemoider |
| DE102007063503A1 (de) * | 2007-12-29 | 2009-07-02 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3137690A (en) * | 1963-09-26 | 1964-06-16 | Searle & Co | 17beta-hydroxy-3-oxoandrost-4-en-17alpha-ylpropionaldehyde lactol and delta1, delta6, delta1, 6, 19-nor and 7alpha-acetylthio congeners |
-
1962
- 1962-04-25 US US191392A patent/US3254074A/en not_active Expired - Lifetime
-
1963
- 1963-07-16 FR FR941651A patent/FR4953M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3254074A (en) | 1966-05-31 |